Renato G. Martins, MD

Articles by Renato G. Martins, MD

Second-line and Third-line Chemotherapy for Lung Cancer: Use and Cost

ByScott D. Ramsey, MD, PhD,Renato G. Martins, MD,David K. Blough, PhD,Lauri S. Tock, MHA,Deborah Lubeck, PhD,Carolina M. Reyes, PhD

May 15th 2008

Using health insurance claims, we identified common first-, second-, and third-line chemotherapy regimens for patients with lung cancer and associated utilization and costs of care.

Latest Updated Articles

Second-line and Third-line Chemotherapy for Lung Cancer: Use and Cost
Published: May 15th 2008 | Updated:

Renato G. Martins, MD

Articles by Renato G. Martins, MD

Second-line and Third-line Chemotherapy for Lung Cancer: Use and Cost

Latest Updated Articles

Trending on AJMC

FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH

In Primary Care–Oncology Collaboration, the Baton Goes Both Ways

Trust and Transparency Key for Leveraging AI to Expand Access to Precision Oncology

FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer

Information and Integration Can Take Oncology Patients From Surviving to Thriving